Overall survival and prognostic factors in patients with spinal metastases from lung cancer treated with and without epidermal growth factor receptor tyrosine kinase inhibitors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overall survival and prognostic factors in patients with spinal metastases from lung cancer treated with and without epidermal growth factor receptor tyrosine kinase inhibitors
Authors
Keywords
Spinal metastasis, Lung cancer, Epidermal growth factor receptor, Prognosis, Molecular targeted therapy
Journal
International Journal of Clinical Oncology
Volume 22, Issue 4, Pages 698-705
Publisher
Springer Nature
Online
2017-03-30
DOI
10.1007/s10147-017-1116-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Effect of Surgery on Quality of Life of Patients with Spinal Metastasis from Non-Small-Cell Lung Cancer
- (2016) Yu Tang et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Evaluation of Scoring Systems and Prognostic Factors in Patients With Spinal Metastases From Lung Cancer
- (2016) Jiong Hao Tan et al. SPINE
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- New prognostic factors and scoring system for patients with skeletal metastasis
- (2014) Hirohisa Katagiri et al. Cancer Medicine
- Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
- (2013) Chee Khoon Lee et al. JNCI-Journal of the National Cancer Institute
- Bone matters in lung cancer
- (2012) T. Brodowicz et al. ANNALS OF ONCOLOGY
- A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer
- (2012) Dirk Rades et al. BMC CANCER
- First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
- (2012) Siow Ming Lee et al. LANCET ONCOLOGY
- Prognostic Scoring Systems for Spinal Metastases in the Era of Anti-VEGF Therapies
- (2012) Thomas M. Gregory et al. SPINE
- 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
- (2011) Christopher G. Azzoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Actual and Predicted Survival Time of Patients With Spinal Metastases of Lung Cancer
- (2011) Christian Hessler et al. SPINE
- Predictive Value of Tokuhashi Scoring Systems in Spinal Metastases, Focusing on Various Primary Tumor Groups
- (2011) Miao Wang et al. SPINE
- First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
- (2009) Akira Inoue et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and Management of Bone Metastases in Lung Cancer: A Review
- (2009) Hamed Al Husaini et al. Journal of Thoracic Oncology
- Predictors of Survival in Patients With Bone Metastasis of Lung Cancer
- (2008) Hideshi Sugiura et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients
- (2008) Ahmed Ibrahim et al. JOURNAL OF NEUROSURGERY-SPINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now